Abbott Revises Its Full-year 2024 EPS Guidance Range To $4.61-$4.71 Versus Prior Guidance Of $4.55-$4.70 And Consensus Of $4.63
Portfolio Pulse from Benzinga Newsdesk
Abbott has revised its full-year 2024 EPS guidance range to $4.61-$4.71, up from the prior guidance of $4.55-$4.70 and above the consensus of $4.63.
July 18, 2024 | 11:39 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Abbott has increased its full-year 2024 EPS guidance range to $4.61-$4.71, which is higher than both its previous guidance and the consensus estimate. This positive revision indicates strong expected performance.
The upward revision of EPS guidance suggests that Abbott is expecting better-than-anticipated financial performance. This is likely to boost investor confidence and positively impact the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100